7.15
price up icon8.38%   0.53
 
loading
Schlusskurs vom Vortag:
$6.62
Offen:
$6.66
24-Stunden-Volumen:
181.31K
Relative Volume:
0.49
Marktkapitalisierung:
$455.21M
Einnahmen:
$555.06M
Nettoeinkommen (Verlust:
$-39.48M
KGV:
-11.92
EPS:
-0.6
Netto-Cashflow:
$29.05M
1W Leistung:
+6.14%
1M Leistung:
+10.73%
6M Leistung:
-31.67%
1J Leistung:
+25.22%
1-Tages-Spanne:
Value
$6.65
$7.21
1-Wochen-Bereich:
Value
$6.33
$7.21
52-Wochen-Spanne:
Value
$5.62
$14.38

Bioventus Inc Stock (BVS) Company Profile

Name
Firmenname
Bioventus Inc
Name
Telefon
(919) 474-6700
Name
Adresse
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Name
Mitarbeiter
930
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-11
Name
Neueste SEC-Einreichungen
Name
BVS's Discussions on Twitter

Vergleichen Sie BVS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
BVS
Bioventus Inc
7.15 455.21M 555.06M -39.48M 29.05M -0.60
Medical Devices icon
ABT
Abbott Laboratories
135.46 233.36B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
104.69 147.06B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
395.75 145.64B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
88.16 112.76B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.13 44.46B 5.54B 4.18B 623.10M 7.00

Bioventus Inc Stock (BVS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-17 Hochstufung JP Morgan Underweight → Neutral
2023-12-07 Hochstufung Canaccord Genuity Hold → Buy
2023-08-09 Hochstufung Craig Hallum Hold → Buy
2022-11-22 Herabstufung Craig Hallum Buy → Hold
2022-11-09 Herabstufung Canaccord Genuity Buy → Hold
2022-11-09 Herabstufung JP Morgan Overweight → Underweight
2022-03-15 Eingeleitet Craig Hallum Buy
2021-11-15 Fortgesetzt Morgan Stanley Overweight
2021-11-10 Fortgesetzt JP Morgan Overweight
2021-07-01 Herabstufung Goldman Buy → Neutral
2021-03-08 Eingeleitet Canaccord Genuity Buy
2021-03-08 Eingeleitet Goldman Buy
2021-03-08 Eingeleitet JP Morgan Overweight
2021-03-08 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Bioventus Inc Aktie (BVS) Neueste Nachrichten

pulisher
Jun 19, 2025

(BVS) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 19, 2025
pulisher
Jun 14, 2025

Do Options Traders Know Something About Bioventus Stock We Don't? - The Globe and Mail

Jun 14, 2025
pulisher
Jun 06, 2025

(BVS) Proactive Strategies - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 06, 2025

Bone Growth Stimulator Market Booming Worldwide with - openPR.com

Jun 06, 2025
pulisher
Jun 04, 2025

bioventus inc. reports results of annual stockholders meeting By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

bioventus inc. reports results of annual stockholders meeting - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Bioventus Holds Annual Meeting, Elects Directors - TipRanks

Jun 04, 2025
pulisher
Jun 02, 2025

Cetera Investment Advisers Sells 1,805 Shares of Bioventus Inc. (NYSE:BVS) - Defense World

Jun 02, 2025
pulisher
May 30, 2025

Bioventus’ Cut Losses 46%, Organic Sales Up 5% - Orthopedics This Week

May 30, 2025
pulisher
May 30, 2025

Millennium Management LLC Sells 60,811 Shares of Bioventus Inc. (NYSE:BVS) - Defense World

May 30, 2025
pulisher
May 26, 2025

Janus Henderson Group PLC Acquires Shares of 17,200 Bioventus Inc. (NYSE:BVS) - Defense World

May 26, 2025
pulisher
May 19, 2025

Balyasny Asset Management L.P. Invests $133,000 in Bioventus Inc. (NYSE:BVS) - Defense World

May 19, 2025
pulisher
May 19, 2025

BNP Paribas Financial Markets Invests $1.66 Million in Bioventus Inc. (NYSE:BVS) - Defense World

May 19, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Has $160,000 Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World

May 18, 2025
pulisher
May 16, 2025

(BVS) On The My Stocks Page - news.stocktradersdaily.com

May 16, 2025
pulisher
May 12, 2025

Bioventus reiterates 2025 guidance with focus on growth and profitability - MSN

May 12, 2025
pulisher
May 08, 2025

Barclays PLC Has $696,000 Holdings in Bioventus Inc. (NYSE:BVS) - Defense World

May 08, 2025
pulisher
May 07, 2025

Bioventus (BVS) Price Target Trimmed by Craig-Hallum Analyst | BVS Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Bioventus Inc. (NASDAQ:BVS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025
pulisher
May 07, 2025

Is Bioventus (NASDAQ:BVS) Using Too Much Debt? - simplywall.st

May 07, 2025
pulisher
May 07, 2025

Bioventus First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Bioventus Inc (BVS) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Divestitures - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Bioventus Inc (BVS) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Divestitures By GuruFocus - Investing.com Canada

May 07, 2025
pulisher
May 07, 2025

Bioventus Reports Q1 2025 Financial Performance - TipRanks

May 07, 2025
pulisher
May 07, 2025

Bioventus: Q1 Earnings Snapshot - CTPost

May 07, 2025
pulisher
May 06, 2025

Bioventus Earnings Call: Growth Amid Challenges - TipRanks

May 06, 2025
pulisher
May 06, 2025

Financial Fitness Check: Examining Bioventus Inc (BVS)’s Key Ratios - DWinneX

May 06, 2025
pulisher
May 06, 2025

Bioventus earnings beat by $0.04, revenue topped estimates - Investing.com Canada

May 06, 2025
pulisher
May 06, 2025

Bioventus Q1 2025 slides: 5% organic growth despite revenue decline, maintains guidance - Investing.com Canada

May 06, 2025
pulisher
May 06, 2025

Earnings call transcript: Bioventus Q1 2025 beats EPS forecast but faces stock dip - Investing.com Nigeria

May 06, 2025
pulisher
May 06, 2025

Bioventus Inc. Q1 Loss Narrows - Nasdaq

May 06, 2025
pulisher
May 06, 2025

Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

Bioventus (BVS) Exceeds Q1 Revenue Expectations with Strong Perf - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Bioventus Inc Q1 2025 Earnings: Revenue Hits $123.9M, Beating Es - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Bioventus (BVS) Exceeds Q1 Revenue Expectations with Strong Performance | BVS Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Bioventus reports Q1 revenue and earnings above estimates, shares dip By Investing.com - Investing.com Nigeria

May 06, 2025
pulisher
May 06, 2025

Bioventus reports Q1 revenue and earnings above estimates, shares dip - Investing.com Australia

May 06, 2025
pulisher
May 06, 2025

Bioventus Reports First Quarter Financial Results | BVS Stock Ne - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Bioventus Reports First Quarter Financial Results - The Manila Times

May 06, 2025
pulisher
May 06, 2025

Bioventus Reports First Quarter Financial Results | BVS Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Bioventus Inc. Reports Q1 2025 Financial Results: Revenue Decline of 4.3% but Organic Growth of 5.0% and Improved Non-GAAP EPS - Nasdaq

May 06, 2025
pulisher
May 06, 2025

Bioventus Inc. SEC 10-Q Report - TradingView

May 06, 2025
pulisher
May 06, 2025

(BVS) Trading Report - news.stocktradersdaily.com

May 06, 2025
pulisher
May 05, 2025

Examining the Future: Bioventus's Earnings Outlook - Nasdaq

May 05, 2025
pulisher
May 05, 2025

Bioventus Inc (BVS) Q1 2025 Earnings Report Preview: What To Look For - GuruFocus

May 05, 2025

Finanzdaten der Bioventus Inc-Aktie (BVS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Bioventus Inc-Aktie (BVS) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Bartholdson John A.
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
72,045
SUTTER MARTIN P
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
85,241
STALNECKER SUSAN M
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
105,957
NOHRA GUY P
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
126,610
NEELS GUIDO J
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
85,241
McMurry-Heath Michelle
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
74,698
Ladone Mary Kay
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
78,981
HAWKINS WILLIAM A
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
257,851
Beyer Pat
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
76,436
Singleton Mark Leonard
SVP & CFO
Apr 11 '25
Sale
7.57
3,875
29,334
141,088
$300.46
price down icon 4.51%
medical_devices PHG
$24.15
price up icon 0.79%
medical_devices STE
$240.86
price up icon 0.35%
$83.84
price down icon 3.93%
$76.51
price up icon 3.36%
medical_devices EW
$77.13
price down icon 1.42%
Kapitalisierung:     |  Volumen (24h):